A First-in-Human Study of CGT4255 in Patients Who Have Advanced Solid Tumors With ERBB2 Alterations or HER2 Overexpression

CGT4255 - Cogent Biosci

https://cattendee.abstractsonline.com/meeting/21487/presentation/4310

D. Westphalen1; S. Goldberg2; M. Rizwan Khawaja3; J. Pacheco4; J. Russell5; J. Sabari6; W-L. Kuo1; M. Little1; R. Moyers1; K. Dorris1; M. Adham Salkeni7

Jul 31, 2026